Reman, Oumedaly <br/><br/>
Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.  [electronic resource] 

 -  The hematology journal : the official journal of the European Haematology Association  2004 
 - 123-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1466-4860 
<br/><br/><label>Standard No.: </label>10.1038/sj.thj.6200353  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Amsacrine--administration & dosage<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Middle Aged<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--pathology<br/>Prognosis<br/>Recurrence<br/>Salvage Therapy<br/>Survival Analysis<br/>Treatment Outcome